Stockreport

Travere Therapeutics to Report Third Quarter 2025 Financial Results

Travere Therapeutics, Inc.  (TVTX) 
PDF SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 20 [Read more]